Rosiglitazone

Rosiglitazone

SCHEMBL3347673

CN(CCOc1ccc(CC2SC(=O)NC2=O)cc1)c1ccccn1.O=C(O)C=CC(=O)O.[KH]

nearest known ligand 0.98

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

PPARG

The experimentally established mechanism targets of Rosiglitazone. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ PPARG known ✓ P37231 12/20 0.98
▸ RARG P13631 1/20 0.98
▸ RXRA P19793 1/20 0.98
▸ PPARA Q07869 2/20 0.56
▸ KMT2A Q03164 1/20 0.52
▸ FFAR1 O14842 6/20 0.50
▸ KDM4E B2RXH2 2/20 0.50
▸ ALDH1A1 P00352 2/20 0.50
▸ MAPT P10636 2/20 0.50
▸ PKM P14618 2/20 0.50
▸ HTT P42858 1/20 0.50
▸ L3MBTL1 Q9Y468 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Rosiglitazone SCHEMBL122053 0.99 PPARG (1.00) PPARGRARGRXRAPPARAKMT2A
Rosiglitazone SCHEMBL19469505 0.99 PPARG (1.00) PPARGRARGRXRAPPARAKMT2A
Rosiglitazone SCHEMBL29376790 0.99 PPARG (1.00) PPARGRARGRXRAPPARAKMT2A
Rosiglitazone SCHEMBL466397 0.99 PPARG (1.00) PPARGRARGRXRAPPARAKMT2A
Rosiglitazone SCHEMBL5556077 0.99 PPARG (1.00) PPARGRARGRXRAPPARAKMT2A
Rosiglitazone SCHEMBL5734118 0.99 PPARG (1.00) PPARGRARGRXRAPPARAKMT2A
Rosiglitazone SCHEMBL504723 0.99 PPARG (1.00) PPARGRARGRXRAPPARAKMT2A
Rosiglitazone SCHEMBL19023 0.99 PPARG (1.00) PPARGRARGRXRAPPARAKMT2A
Rosiglitazone SCHEMBL29757195 0.99 PPARG (1.00) PPARGRARGRXRAPPARAKMT2A
Rosiglitazone SCHEMBL3629161 0.98 PPARG (0.98) PPARGRARGRXRAPPARAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010067136-A1 NOVEL CRYSTALLINE FORMS RICHTER GEDEON NYRT. (HU) 2010-06-17 — — WO claimed
CN-101203223-A Pharmaceutical composition comprising amorphous rosiglitazone SMITHKLINE BEECHAM CORP (US) 2008-06-18 — — CN claimed
EP-1853262-A1 PHARMACEUTICAL COMPOSITION COMPRISING AMORPHOUS ROSIGLITAZONE SMITHKLINE BEECHAM CORPORATION (US) 2007-11-14 — — EP claimed
WO-2006090150-A1 PHARMACEUTICAL COMPOSITION COMPRISING AMORPHOUS ROSIGLITAZONE SMITHKLINE BEECHAM CORPORATION (US) 2006-08-31 — — WO claimed
US-20060083784-A1 Amorphous pharmaceutical compositions SMITHKLINE BEECHAM CORPORATION 2006-04-20 — — US claimed
WO-2010067136-A1 NOVEL CRYSTALLINE FORMS RICHTER GEDEON NYRT. (HU) 2010-06-17 — — WO disclosed
CN-101203223-A Pharmaceutical composition comprising amorphous rosiglitazone SMITHKLINE BEECHAM CORP (US) 2008-06-18 — — CN disclosed
EP-1853262-A1 PHARMACEUTICAL COMPOSITION COMPRISING AMORPHOUS ROSIGLITAZONE SMITHKLINE BEECHAM CORPORATION (US) 2007-11-14 — — EP disclosed
WO-2006090150-A1 PHARMACEUTICAL COMPOSITION COMPRISING AMORPHOUS ROSIGLITAZONE SMITHKLINE BEECHAM CORPORATION (US) 2006-08-31 — — WO disclosed
US-20060083784-A1 Amorphous pharmaceutical compositions SMITHKLINE BEECHAM CORPORATION 2006-04-20 — — US disclosed
EP-1475378-A1 Antidiabetic thiazolidinedione potassium salt RICHTER GEDEON VEGYESZETI GYAR R.T. (HU) 2004-11-10 — — EP disclosed
EP-1242418-B1 ANTIDIABETIC THIAZOLIDINEDIONES AND THEIR PREPARATION RICHTER GEDEON VEGYESZET (HU) 2004-10-27 — — EP disclosed
EP-1242418-A1 ANTIDIABETIC THIAZOLIDINEDIONES AND THEIR PREPARATION RICHTER GEDEON VEGYESZETI GYAR R.T. (HU) 2002-09-25 — — EP disclosed
WO-2001044240-A1 ANTIDIABETIC THIAZOLIDINEDIONES AND THEIR PREPARATION Richter Gedeon Vegyészeti Gyár Rt. (HU) 2001-06-21 — — WO disclosed
Send feedback